Pharmacovigilance study of the association between dipeptidyl peptidase–4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)

por Ohyama, Katsuhiro, Shindo, Junichiro, Takahashi, Tomohiro, Takeuchi, Hironori, Hori, Yusuke
Publicado 2022